A PRELIMINARY-REPORT OF SAFETY FOR A PHASE-II TRIAL OF DUP-937 (AN ANTHRAPYRAZOLE) IN SOLID TUMORS

被引:0
|
作者
DALLAIRE, B [1 ]
FRANCHER, D [1 ]
AZARNIA, N [1 ]
WIELGOSZ, G [1 ]
ADAMS, D [1 ]
LYNCH, W [1 ]
VARNS, C [1 ]
BUNITSKY, K [1 ]
VANDERTUIN, L [1 ]
GRACE, M [1 ]
CARON, M [1 ]
BARBU, M [1 ]
SISK, R [1 ]
STOLTZFUS, K [1 ]
CARLSON, R [1 ]
GRILLOLOPEZ, A [1 ]
GYVES, J [1 ]
机构
[1] DUPONT MERCK PHARMACEUT CO,WILMINGTON,DE
来源
CLINICAL RESEARCH | 1992年 / 40卷 / 02期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A420 / A420
页数:1
相关论文
共 50 条
  • [31] PRELIMINARY-REPORT OF PHASE-I AND PHASE-II CLINICAL INVESTIGATION OF HUMAN-FVIII DERIVED FROM RECOMBINANTS DNA
    SCHWARTZ, RS
    ABILDGAARD, C
    ALEDORT, L
    BLOOM, A
    BRACKMANN, H
    BRETTLER, D
    DIETRICH, S
    EGLI, J
    FUJIMAKI, M
    FUKUI, H
    HILGARTNER, M
    INWOOD, M
    KASPER, C
    KERNOFF, P
    LEVINE, P
    LUSHER, J
    MANNUCCI, P
    SCHARRER, I
    ALLRED, R
    COX, C
    FALLISE, J
    KUO, H
    MACKENZIE, S
    MARUHN, D
    NEUMANN, R
    PANCHAM, N
    PENNINGTON, J
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 181 - 181
  • [32] PHASE-II TRIAL OF CHLOROZOTOCIN IN MALIGNANT-MELANOMA, BREAST-CANCER, AND OTHER SOLID TUMORS
    SILVER, BA
    BARLOCK, AL
    LIPPMAN, ME
    ANDERSON, T
    FISHER, RI
    CANCER TREATMENT REPORTS, 1982, 66 (05): : 1229 - 1230
  • [33] DIANHYDROGALACTITOL (NSC-132313) - PHASE-II STUDY IN SOLID TUMORS - REPORT OF THE EORTC EARLY CLINICAL-TRIAL COOPERATIVE GROUP
    DEJAGER, R
    BRUGAROLAS, A
    HANSEN, H
    CAVALLI, F
    RYSSEL, H
    SIEGENTHALER, P
    CLARYSSE, A
    RENARD, J
    KENIS, Y
    ALBERTO, P
    EUROPEAN JOURNAL OF CANCER, 1979, 15 (07) : 971 - 974
  • [34] PHASE-I - PRELIMINARY PHASE-II TRIAL OF IPROPLATIN, A CISPLATIN ANALOG
    PAOLOZZI, FP
    GAVER, R
    POIESZ, BJ
    LOUIE, A
    DIFINO, S
    COMIS, RL
    NEWMAN, N
    GINSBERG, S
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (03) : 199 - 206
  • [35] Preliminary safety and efficacy of tinengotinib tablets as monotherapy and combination therapy in advanced solid tumors: A phase Ib/II clinical trial
    Piha-Paul, Sarina A.
    Goel, Sanjay
    Liao, Chih-Yi
    Gabrail, Nashat Y.
    Dayyani, Farshid
    Kazmi, Syed Mohammad Ali
    Yuan, Yuan
    Lavasani, Sayeh Moazami
    Fan, Jean
    Peng, Peng
    Sun, Caixia
    Wang, Hui
    Hennessy, Katie
    Fu, Ximei
    Ni, Shumao
    Tan, Hui Xian
    Ngo, Brenda
    Ru, Qinhua Cindy
    Wu, Frank
    Javle, Milind M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] PHASE-II STUDY OF MULTIPLE DAILY FRACTIONATIONS IN THE PALLIATION OF ADVANCED PELVIC MALIGNANCIES - PRELIMINARY-REPORT OF RTOG-8502
    SPANOS, W
    GUSE, C
    PEREZ, C
    GRIGSBY, P
    DOGGETT, RLS
    POULTER, C
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (03): : 659 - 661
  • [37] A BROAD PHASE-II EVALUATION OF MAYTANSINE (MTS) IN ADVANCED SOLID TUMORS
    RAVRY, MJR
    LOWENBRAUN, S
    BIRCH, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 154 - 154
  • [38] PHASE-II TRIAL OF VINBLASTINE SULFATE FOR METASTATIC UROTHELIAL TRACT TUMORS
    BLUMENREICH, MS
    YAGODA, A
    NATALE, RB
    WATSON, RC
    CANCER, 1982, 50 (03) : 435 - 438
  • [39] PHASE-II TRIAL OF VINDESINE IN PATIENTS WITH GERM-CELL TUMORS
    REYNOLDS, TF
    VUGRIN, D
    CVITKOVIC, E
    GRALLA, RJ
    YOUNG, CW
    GOLBEY, RB
    CANCER TREATMENT REPORTS, 1979, 63 (08): : 1399 - 1401
  • [40] PHASE-II TRIAL OF MITOGAUZONE IN MALIGNANT PRIMARY BRAIN-TUMORS
    FEUN, LG
    YUNG, WKA
    STEWART, DJ
    SAVARAJ, N
    BODEY, GP
    CANCER TREATMENT REPORTS, 1985, 69 (03): : 329 - 330